Search for other papers by Hoda Gad in
Google Scholar
PubMed
Search for other papers by Einas Elgassim in
Google Scholar
PubMed
Department of Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
Search for other papers by Ibrahim Mohammed in
Google Scholar
PubMed
Search for other papers by Ahmad Yaser Alhaddad in
Google Scholar
PubMed
Search for other papers by Hussein Ahmed Hussein Zaky Aly in
Google Scholar
PubMed
Search for other papers by John-John Cabibihan in
Google Scholar
PubMed
Search for other papers by Abdulaziz Al-Ali in
Google Scholar
PubMed
Search for other papers by Kishor Kumar Sadasivuni in
Google Scholar
PubMed
Search for other papers by Aliyaa Haji in
Google Scholar
PubMed
Search for other papers by Neila Lamine in
Google Scholar
PubMed
Search for other papers by Adnan Khan in
Google Scholar
PubMed
Search for other papers by Ioannis N Petropoulos in
Google Scholar
PubMed
Search for other papers by Georgios Ponirakis in
Google Scholar
PubMed
Search for other papers by Alise Kalteniece in
Google Scholar
PubMed
Search for other papers by Maryam Ferdousi in
Google Scholar
PubMed
Search for other papers by Shazli Azmi in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK
Division of Endocrinology, Diabetes and Gastroenterology, University of Manchester, Manchester, UK
Search for other papers by Uazman Alam in
Google Scholar
PubMed
Search for other papers by Wajeeha Abuhelaiqa in
Google Scholar
PubMed
Search for other papers by Amin Jayyousi in
Google Scholar
PubMed
Search for other papers by Dabia AlMohanadi in
Google Scholar
PubMed
Search for other papers by Khaled Baagar in
Google Scholar
PubMed
Institute of Cardiovascular Medicine, University of Manchester, Manchester, UK
Search for other papers by Rayaz A Malik in
Google Scholar
PubMed
Pharmacology and Toxicology 2018 122 165 – 175 . ( https://doi.org/10.1111/bcpt.12870 ) 43 Jamali R Mohseni S . Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats . Acta
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
anophtalmia, PMR, cryptorchidism 2.3 −4.4 −4.0 −3.1 −3.8 2 M 13.1 −1.7 1.1 CHT, CAI, HH Pituitary hyperplasia – 3.5 −3.4 −1.3 +0.3 +1.0 3 M 10.3 BDL 0.3 CHT NA Neonatal hypoglycaemia 1.1 −5.4 −3
Search for other papers by Marilena Nakaguma in
Google Scholar
PubMed
Search for other papers by Fernanda A Correa in
Google Scholar
PubMed
Search for other papers by Lucas S Santana in
Google Scholar
PubMed
Search for other papers by Anna F F Benedetti in
Google Scholar
PubMed
Search for other papers by Ricardo V Perez in
Google Scholar
PubMed
Search for other papers by Martha K P Huayllas in
Google Scholar
PubMed
Search for other papers by Mirta B Miras in
Google Scholar
PubMed
Search for other papers by Mariana F A Funari in
Google Scholar
PubMed
Search for other papers by Antonio M Lerario in
Google Scholar
PubMed
Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed
Search for other papers by Luciani R S Carvalho in
Google Scholar
PubMed
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
measurement during hypoglycaemia and IGF-1 and IGFBP-3 levels less than −2 SDS for age and sex. As patients were studied at different centres using different hormonal assays, normal ranges of each centre were considered. Target gene panel Genomic DNA was
Search for other papers by Magnus F G Grøndahl in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit Van Hall in
Google Scholar
PubMed
Search for other papers by Nicolai J W Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark
Copenhagen Center for Translational Research, Copenhagen University Hospital – Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Mikkel B Christensen in
Google Scholar
PubMed
Search for other papers by Asger B Lund in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Introduction The peptide hormone glucagon increases hepatic glucose production and is secreted from the pancreatic alpha cells when glucose mobilisation via gluconeogenesis or glycogenolysis is needed, e.g. during hypoglycaemia ( 1 ). Besides
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Sophie Howarth in
Google Scholar
PubMed
Search for other papers by Luca Giovanelli in
Google Scholar
PubMed
Search for other papers by Catherine Napier in
Google Scholar
PubMed
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Simon H Pearce in
Google Scholar
PubMed
loss, hypoglycaemia and fatigue. Historically, the symptomatic phase was felt to be a point of no return for Addison’s patients, with a lifelong requirement for steroid replacement to avoid fatal adrenal crisis. However, a growing body of evidence
Search for other papers by Tatiana V Novoselova in
Google Scholar
PubMed
Search for other papers by Peter J King in
Google Scholar
PubMed
Search for other papers by Leonardo Guasti in
Google Scholar
PubMed
Search for other papers by Louise A Metherell in
Google Scholar
PubMed
Search for other papers by Adrian J L Clark in
Google Scholar
PubMed
Search for other papers by Li F Chan in
Google Scholar
PubMed
( 10 ). Patients with FGD usually present in the neonatal period or early childhood with symptoms of hypocortisolaemia such as hypoglycaemia, failure to thrive, recurrent infections, collapse and seizures along with severe hyperpigmentation due to the
Search for other papers by Molly L Tanenbaum in
Google Scholar
PubMed
Search for other papers by Persis V Commissariat in
Google Scholar
PubMed
Thiele-Schmitz S Schröder C Steigleder-Schweiger C & Holl RW . Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1
Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed
Search for other papers by Othmar Moser in
Google Scholar
PubMed
Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed
Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed
Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed
Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed
Search for other papers by Harald Sourij in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Faculty of Medicine, University of Latvia, Riga, Latvia
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
comparing the cross-interactions of incretins such as GLP-1 and pancreatic hormones − insulin and glucagon − during the caloric restriction with postprandial hormonal changes ( Fig. 1 ). In a state of hypoglycaemia, increased glucagon secretion prompts the
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Eka Melson in
Google Scholar
PubMed
Search for other papers by Agnes Johnson in
Google Scholar
PubMed
Search for other papers by Lucy Wallett in
Google Scholar
PubMed
Search for other papers by Lucretia Thomas in
Google Scholar
PubMed
Search for other papers by Dengyi Zhou in
Google Scholar
PubMed
Search for other papers by Catherine Holmes in
Google Scholar
PubMed
Search for other papers by Agata Juszczak in
Google Scholar
PubMed
Search for other papers by Mohammed Ali Karamat in
Google Scholar
PubMed
Search for other papers by Sandip Ghosh in
Google Scholar
PubMed
Search for other papers by Wasim Hanif in
Google Scholar
PubMed
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Search for other papers by Parth Narendran in
Google Scholar
PubMed
School of Life and Health Sciences, Aston University, Birmingham, UK
Search for other papers by Srikanth Bellary in
Google Scholar
PubMed
hypoglycaemia (glucose < 4 mmol/L), hypokalaemia (K+ < 3.5 mmol/L) and hyperkalaemia (K+ > 5.5 mmol/L) during DKA episodes were also recorded. In cases where the same patient was included twice in the data set for separate DKA episodes, the episodes were
Search for other papers by Fiona Broughton Pipkin in
Google Scholar
PubMed
Search for other papers by Hiten D Mistry in
Google Scholar
PubMed
Search for other papers by Chandrima Roy in
Google Scholar
PubMed
Search for other papers by Bernhard Dick in
Google Scholar
PubMed
Search for other papers by Jason Waugh in
Google Scholar
PubMed
Search for other papers by Rebecca Chikhi in
Google Scholar
PubMed
Search for other papers by Lesia O Kurlak in
Google Scholar
PubMed
Search for other papers by Markus G Mohaupt in
Google Scholar
PubMed
birth weight due to congenital infections such as cytomegalovirus, dysmorphism, twins, severe cerebral palsy, congenital heart disease, acute infections, hyaline membrane disease or other respiratory disease, jaundice, hypoglycaemia or with a history of